期刊文献+

小剂量氢氯噻嗪与卡托普利用于社区联合降压疗效观察 被引量:1

下载PDF
导出
摘要 原发性高血压是损害心、脑、肾、眼、血管等器官最重要的危险因素之一。虽然各国已认识到控制血压可明显改善上述器官疾病预后,但血压控制仍很不理想,尤其在我国。其原因主要与单一药物控制率低、降压药物费用高、依从性差等因素有关。因此廉价的小剂量降压药联合应用受到了广泛关注。
出处 《河北医药》 CAS 2012年第10期1518-1519,共2页 Hebei Medical Journal
  • 相关文献

参考文献7

  • 1丁绍祥.小剂量药物联合治疗高血压的可行性研究[J].中国全科医学,2011,14(35):4038-4041. 被引量:14
  • 2刘力生,龚兰生.中国高血压防治指南(试行本)[J].高血压杂志,2000,8(1):94-102. 被引量:945
  • 3The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients ran- domized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic : The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA, 2002,288: 2981- 2997.
  • 4Pitt B, Zannad F, Remme WJ. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med, 1999, 341:709-717.
  • 5赵海燕,吴寿岭,孙立霞,李云,侯国盛,刘福山,王黎光,吴云涛.氢氯噻嗪与螺内酯、卡托普利联合治疗原发性高血压[J].高血压杂志,2006,14(1):23-27. 被引量:23
  • 6Gallagher AM, Yu H, Printz MP. Bradykinin-induced reduction in colla- gen gene expression involves prostacyclin. Hypertension, 1998,32 : 84- 88.
  • 7Radevski IV,Vahchanova ZP, Candy GP, et al. Antihypertensive effect of low-dose hydrochlorothiazide alone or in combination with quinapril in black patients with mild to moderate hypertension. J Clin Phannacol, 2000,40:713-721.

二级参考文献24

  • 1丁绍祥.原发性高血压发病机制及治疗探讨[J].航空航天医学杂志,2009,21(10):30-32. 被引量:22
  • 2全国血压抽样调查协作组.中国高血压的患病率、知晓率及治疗和控制状况:1991年抽样调查结果[J].高血压杂志,1995,3(A01):14-18. 被引量:199
  • 3Puig JG, Miranda, Mateos F, et al. Hydrochlorothiazide versus spironolactones: long-term metabolic modifications in patients with essential hypertension[J]. J Clin Pharmacol, 1991,31: 455-461.
  • 4The ALLHAT officers and coordinators for the ALLHAT Collaborative research group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-coverting enzyme inhibitors and enzyme inhibitor or calcium channel blocker vs diuretic[J]. J AMA, 2002,288: 2981-2997.
  • 5Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on the prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report[J]. JAMA, 2003,289: 2560-2572.
  • 6Henty M, Wehrlen M, Pelletier B, et al. Spironolactone versus nifedipine in essential hypertension[J]. Am J Cardiol, 1990,65:K36.
  • 7Dveymea JM. Clinical update: spironolactone and aldactone as monotherapy in systemic hypertension[J]. Am J Cardiol, 1990,65:K20.
  • 8Nishizaka MK, Zaman MA, Calhoun DA. Efficacy of low dose spironolactone in subjects with resistant hypertension[J]. Am J Hypertens, 2003,16: 925-930.
  • 9The RALES inestigators, effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic heart failure[J]. Am J cardiol, 1996,78: 902-907.
  • 10Faize BD, Francois A. Treatment of congestive heart failure interfering the aldosterone-cardiac extracelluar matrix relationship[J]. Hypertension,2001,38: 1227-1232.

共引文献979

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部